Covidien PLC http://www.alacrastore.com/company-snapshot/Covidien_PLC-4006279 27 Nov 2009 06:11:34 EST 4006279 Covidien PLC en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/T2550699T2550699ccbn/T2550699norm18 Nov 2009 02:06:15 EST2550699Final Transcript of COV presentation, 18-Nov-09 11:30am ETCovidien Plc.106.0000FinalCovidien Plc. at Lazard Capital Healthcare Conference TranscriptCOV11:30am ETTranscript...Sean Lavin - Lazard Capital Markets - Analyst We're very happy to have Covidien here with us today. I think most of you know Covidien, but obviously one of the world's most diversified and leading medical technology companies. We have Cole Lannum, Vice President of Investor Relations. He is going to give some very brief remarks and then open to your questions. Thank you. Cole Lannum - Covidien plc - VP of IR Thank you very much, Sean, and thank you for having me here. As I think some of you may know, we just released our fiscal fourth-quarter results yesterday. So it's been a busy ##-hour period for us, but I think in some ways, a bit timely so that we can talk about some things that we haven't been able to talk about recently. Just -- I'll give you an update on things. I don't want to spend too much time droning on things. We tend to drone a lot about the business. I think most of you are fairly familiar. I want to give enough time to dedicate to Q&A and do that effectively. Obviously,... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2473977B2473977ccbn/B2473977norm17 Nov 2009 11:06:00 EST2473977Edited Brief of COV earnings conference call or presentation, 17-Nov-09 8:30am ETCovidien Plc.106.0000EditedCovidien Plc. Q4 2009 Earnings Conference Call SummaryCOV8:30am ET...David Roman Goldman Sachs - Analyst Kristen Stewart Credit Suisse - Analyst Bob Hopkins BAS-ML - Analyst Matthew Dodds Citigroup - Analyst Rick Wise Leerink Swann - Analyst David Lewis Morgan Stanley - Analyst Thom Gunderson Piper Jaffray - Analyst Glenn Novarro RBC Capital Markets - Analyst Adam Feinstein Barclays Capital - Analyst Joanne Wuensch BMO Capital Markets - Analyst Taylor Harris JPMorgan - Analyst... BriefCredit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2473977T2473977ccbn/T2473977norm17 Nov 2009 10:06:00 EST2473977Final Transcript of COV earnings conference call or presentation, 17-Nov-09 8:30am ETCovidien Plc.106.0000FinalCovidien Plc. Q4 2009 Earnings Conference Call TranscriptCOV8:30am ETTranscript...David Roman Goldman Sachs - Analyst Kristen Stewart Credit Suisse - Analyst Bob Hopkins BAS-ML - Analyst Matthew Dodds Citigroup - Analyst Rick Wise Leerink Swann - Analyst David Lewis Morgan Stanley - Analyst Thom Gunderson Piper Jaffray - Analyst Glenn Novarro RBC Capital Markets - Analyst Adam Feinstein Barclays Capital - Analyst Joanne Wuensch BMO Capital Markets - Analyst Taylor Harris JPMorgan - Analyst... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2536609T2536609ccbn/T2536609norm11 Nov 2009 08:05:00 EST2536609Final Transcript of COV presentation, 11-Nov-09 5:00pm ETCovidien Plc.54.0000FinalCovidien Plc. at Credit Suisse Healthcare Conference TranscriptCOV5:00pm ETTranscript...Kristen Stewart - Credit Suisse - Analyst All right. So without further ado, we have Covidien here to do a little presentation. We will probably have some time for Q&A here in this session, so as we go through the presentation, you can think about things you'd like to ask. It's my pleasure to introduce Chuck Dockendorff, who is the Chief Financial Officer of Covidien. So, Chuck, take it away. Chuck Dockendorff - Covidien PLC - CFO Thank you, Kristen. Good afternoon, everybody. So today we'd like to quickly review some of the accomplishments that we've had at Covidien over the past year, talk about some of the key challenges that are facing us as an organization, and then finally, talking more about the long-term goals and opportunities we see going forward to drive some shareholder value for Covidien. And I would refer you to the forward-looking statements, as we will be talking about some of the projections going forward. But basically, in ####, some of the key accomplishments that we've... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/research/fitch-ratings-Credit_Update_Covidien_plc-477810_report_frame477810_report_framefitch/477810_report_framepdfCovidien PLC8580007328 Oct 2009 06:33:00 EST01031700165Credit UpdateCOVFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.ARGDEUESPGBRINDMEXRUSUSA010100000101010001020000010300000103100001031700020200000300000003010000030108000302000003030000040000000401000004020000Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38909099BW-0001-38909099newstex/BW-0001-38909099xmlNewstex Inc.2005Zacks.comNewstex Inc.newstex.comnewstexBW-0001-38909099Business Wire0001Business WireBW1Newstex Inc.Business Wire040000000400900004016000040160480401600104016018040070000400700516 Oct 2009 06:19:17 EST18000000180080001800400010/16/2009 Oct. ##, #### (Business Wire) -- Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one Zacks ## Rank Strong Buy or a Zacks ## Rank Buy stock for each of the...CASEYS GENERAL STORES INCCOVIDIEN LTD.RPM INTERNATIONAL INCTARGET CORPCASYCOVRPMTGTNewsNewstexJAPAN - Century Medical Inc, a wholly-owned subsidiary of Itochu Corp, agreed to acquire the domestic spinal system sales business of Showa Ika Kohgyo Co Ltd, a Toyohashi, Aichi-based manufacturer and wholesaler of medical devices.01 Oct 2009 06:53:19 EST15662W83775V22304J82753YCentury Medical IncShowa Ika Kohgyo Co Ltd -Domestic Spinal System Sales BusinessCovidien PLCShowa Ika Kohgyo Co Ltdhttp://www.alacrastore.com/storecontent/Thomson_M%26A/Century_Medical_Inc_acquires_Showa_Ika_Kohgyo_Domestic_Spin_from_Showa_Ika_Kohgyo_Co_Ltd-2113098040sdc/21130980402113098040Copyright © 2009, Thomson Financial, All Rights ReservedMeasuring, Medical, Photo Equipment; ClocksJapanSurgical and medical instruments and apparatus3841FFForeignSubsidiary3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies5047:Medical, dental, and hospital equipment & supplies8071:Medical laboratories2834:Pharmaceutical preparations3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies3845:Electromedical and electrotherapeutic apparatus5047:Medical, dental, and hospital equipment & supplies5122:Drugs, drug proprietaries, and druggists' sundriesMeasuring, Medical, Photo Equipment; ClocksJapanSurgical and medical instruments and apparatus3841FFForeignSubsidiary160982002Mnfr,whl healthcare prodMnfr,whl medical devicesUnspecifiedAssets1107936001Oct 1 20090.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.00000Century Medical Inc,headquartered in Tokyo, Japan,manufacture and wholesalesmedical devices related tocardiovascular, orthopedics,critical & respiratory care,etc. The company was foundedin 1974.Century Medical Inc, headquartered in Tokyo, Japan,manufacture and wholesales medical devices related tocardiovascular, orthopedics, critical & respiratory care,etc. The company was founded in 1974.Century Medical Inc, headquartered in Tokyo, Japan, manufacture and wholesales medical devices related to cardiovascular, orthopedics, critical & respiratory care, etc. The company was founded in 1974.1.000002.000003.000004.000005.00000Showa Ika Kohgyo Co Ltd'sdomestic spinal system salesbusiness deals with wholesalesof spinal system to domesticclients.Showa Ika Kohgyo Co Ltd's domestic spinal system salesbusiness deals with wholesales of spinal system to domesticclients.Showa Ika Kohgyo Co Ltd's domestic spinal system sales business deals with wholesales of spinal system to domestic clients.0.000000.000000.000000.00000Y30 Sep 09Wed, 30 Sep 2009 00:00:00 ESTDate Announced: 09/30/2009Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.000000.000000.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.00000JAPAN - Century Medical Inc,a wholly-owned subsidiary ofItochu Corp, agreed toacquire the domestic spinalsystem sales business ofShowa Ika Kohgyo Co Ltd, aToyohashi, Aichi-basedmanufacturer and wholesalerof medical devices.JAPAN - Century Medical Inc, a wholly-owned subsidiary of Itochu Corp, agreed to acquire the domestic spinal system sales business of Showa Ika Kohgyo Co Ltd, a Toyohashi, Aichi-based manufacturer and wholesaler of medical devices.JAPAN - Century Medical Inc, a wholly-owned subsidiary of Itochu Corp, agreed to acquirethe domestic spinal system sales business of Showa Ika Kohgyo Co Ltd, a Toyohashi,Aichi-based manufacturer and wholesaler of medical devices.JAPAN - Century Medical Inc, a wholly-owned subsidiary of Itochu Corp, agreed to acquire the domestic spinal system sales business of Showa Ika Kohgyo Co Ltd, a Toyohashi, Aichi-based manufacturer andwholesaler of medical devices.JAPAN - Century Medical Inc, a wholly-owned subsidiary of Itochu Corp, agreed to acquire the domestic spinal system sales business ofShowa Ika Kohgyo Co Ltd, a Toyohashi, Aichi-based manufacturer and wholesaler of medical devices.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000003841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies8071:Medical laboratories676741003New YorkIreland-Rep3841ForeignPublicCOV3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies8071:Medical laboratories101660001Japan3841ForeignPrivate0.000000.000000.000000.00000Deal InformationTF Mergers & AcquisitionsUS - Transformer Delaware Corp, a wholly-owned unit of Covidien PLC's US Surgical Corp subsidiary, definitively agreed to acquire the entire share capital of Aspect Medical Systems Inc, a Norwood-based manufacturer of brain monitoring equipment, via a tender offer for USD ## in cash per share, or a total value of USD ###.### mil.29 Sep 2009 10:03:25 EST86531Q04523522304J045235Transformer Delaware CorpAspect Medical Systems IncCovidien PLCAspect Medical Systems Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/Transformer_Delaware_Corp_acquires_Aspect_Medical_Systems_Inc-2112200020sdc/21122000202112200020Copyright © 2009, Thomson Financial, All Rights ReservedMeasuring, Medical, Photo Equipment; ClocksUnited StatesSurgical and medical instruments and apparatus3841DEDelawareSubsidiary2834:Pharmaceutical preparations3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies3845:Electromedical and electrotherapeutic apparatus5047:Medical, dental, and hospital equipment & supplies5122:Drugs, drug proprietaries, and druggists' sundries2834:Pharmaceutical preparations3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies3845:Electromedical and electrotherapeutic apparatus5047:Medical, dental, and hospital equipment & supplies5122:Drugs, drug proprietaries, and druggists' sundriesNasdaqMeasuring, Medical, Photo Equipment; ClocksUnited StatesElectromedical and electrotherapeutic apparatus3845MAMassachusettsPublicASPM1107448001Mnfr,whl healthcare prodMnfr brain monitoring equipCashCash OnlyCommon Stock357935002Sep 29 20090.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.00000Transformer Delaware Corp is amanufacturer and wholesalerhealthcare productsheadquartered in the US.Transformer Delaware Corp is a manufacturer and wholesalerhealthcare products headquartered in the US.Transformer Delaware Corp is a manufacturer and wholesaler healthcare products headquartered in the US.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.00000Aspect Medical Systems Inc,based in Norwood,Massachusetts, manufacturesbrain monitoring equipmentcalled the BIS system, whichenables anesthesia providersto assess and manage apatient's level ofconsciousness during surgery.The company was founded in1987.Aspect Medical Systems Inc, based in Norwood, Massachusetts,manufactures brain monitoring equipment called the BISsystem, which enables anesthesia providers to assess andmanage a patient's level of consciousness during surgery.The company was founded in 1987.Aspect Medical Systems Inc, based in Norwood, Massachusetts, manufactures brain monitoring equipment called the BIS system, which enables anesthesia providers to assess and manage a patient's level of consciousness during surgery. The company was founded in 1987.0.000000.000000.0000017.44000YU.S. Dollar28 Sep 09Mon, 28 Sep 2009 00:00:00 ESTDate Announced: 09/28/2009Date Effective:MergerFriendly0.000000.000000.000000.000000.0000012.00000Price/Share0.00000209.288 U.S. Dollar209.28800209.28800209.288 U.S. Dollar209.288000.000000.0000012.0000012.00000209.28800209.288 U.S. Dollar1.00000N131.835008.000000.000000.000008.000000.00000209.28800209.288000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.00000US - Transformer DelawareCorp, a wholly-owned unit ofCovidien PLC's US SurgicalCorp subsidiary, definitivelyagreed to acquire the entireshare capital of AspectMedical Systems Inc, aNorwood-based manufacturer ofbrain monitoring equipment,via a tender offer for USD 12in cash per share, or a totalvalue of USD 209.288 mil.US - Transformer Delaware Corp, a wholly-owned unit of Covidien PLC's US Surgical Corp subsidiary, definitively agreed to acquire the entire share capital of Aspect Medical Systems Inc, a Norwood-based manufacturer of brain monitoring equipment, via a tender offer for USD 12 in cash per share, or a total value of USD 209.288 mil.US - Transformer Delaware Corp, a wholly-owned unit of Covidien PLC's US Surgical Corpsubsidiary, definitively agreed to acquire the entire share capital of Aspect MedicalSystems Inc, a Norwood-based manufacturer of brain monitoring equipment, via a tenderoffer for USD 12 in cash per share, or a total value of USD 209.288 mil.US - Transformer Delaware Corp, a wholly-owned unit of Covidien PLC's US Surgical Corp subsidiary, definitively agreed to acquire the entire share capital of Aspect Medical Systems Inc, aNorwood-based manufacturer of brain monitoring equipment, via a tender offer for USD 12 in cash per share, or a total value of USD 209.288 mil.US - Transformer Delaware Corp, a wholly-owned unit of Covidien PLC's US Surgical Corp subsidiary, definitively agreed to acquire theentire share capital of Aspect Medical Systems Inc, a Norwood-based manufacturer of brain monitoring equipment, via a tender offer forUSD 12 in cash per share, or a total value of USD 209.288 mil.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000003845:Electromedical and electrotherapeutic apparatus8731:Commercial physical and biological research676741003New YorkIreland-Rep3841ForeignPublicCOV3845:Electromedical and electrotherapeutic apparatus8731:Commercial physical and biological research357935002NasdaqUnited States3845MassachusettsPublicASPM209.28800209.28800209.28800131.83500Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/research/s-and-p-credit-research-Summary_Covidien_Ltd-747353747353spcred/747353normglobal18 Sep 2009 10:26:42 EST175SummaryThe latest Summary from S&PUnited StatesHealth Care EquipmentUnited StatesGlobal IssuersSummaryUSA35101010 351010 3510 35Covidien Ltd.412374USACOVSUMMARYCapitalCORPGLOBISSCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/T2400953T2400953ccbn/T2400953norm15 Sep 2009 10:06:00 EST2400953Final Transcript of COV presentation, 15-Sep-09 2:45pm ETCovidien Plc.54.0000FinalCovidien Plc. at Morgan Stanley Global Healthcare Conference TranscriptCOV2:45pm ETTranscript...David Lewis - Morgan Stanley - Analyst Okay, let's go and get started here. Thanks for joining us here. I'm David Lewis, Medical Technology Analyst here for Morgan Stanley. It's my pleasure to have with us here Covidien and the CEO, Rich Meelia. We're coming sort of fresh off the Covidien Analyst Day recently here, where I think we had a nice delineation of where the growth is going to come from, from Covidien as well as an understanding of sort of where the Company is, and sort of their post-spin years on cost restructuring and margin leverage. I think it was overwhelmingly positive. So what I want to do is just frame the debate and then turn it over to Rich just to give us the macro overview here of Covidien. But I think frankly, the debate on Covidien has really been tied to mix-driven margin improvement and tight cost controls. I think what we have seen certainly coming clear the last three to four quarters is, Covidien is certainly delivering on that message of driving positive mix... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/fitch/465796_report_frame465796_report_framefitch/465796_report_framepdfEli Lilly & CompanyLifepoint Hospitals, Inc.Covidien PLCTenet Healthcare CorporationPfizer Inc.Allergan, Inc.McKesson CorporationJohnson & JohnsonWyethAbbott LaboratoriesDaVita, Inc.Owens & Minor, Inc.Medco Health Solutions, IncAmerisourceBergen CorporationWatson Pharmaceuticals, Inc.HCA Inc.Amgen, Inc.Community Health Systems, Inc.Bristol-Myers Squibb CompanyLife Technologies CorporationMerck & Company, Inc.Beckman Coulter, Inc.Baxter International, Inc.Health Management Associates, Inc.Thermo Fisher Scientific IncUniversal Health Services, Inc.St. Jude Medical, Inc.Schering-Plough CorporationCardinal Health, Inc.Express Scripts, Inc.Boston Scientific Corporation8009020680361419816834998009174080089368800917738009111380090628800900878009159181841365800893698008991881841371800895268009116682508772816096558580007380361630803613728184138080710410806562368168347280361592800910138084388485094473829531258009208711 Sep 2009 06:34:00 EST01031700275Special ReportLPNTOMIPFECYHWPITHCABTLLYDVABMYHMATMOWYEBAXAMGNESRXLIFEMHSABCMRKJNJBSXCAHCOVAGNMCKBECSTJSGPUHSFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Credit & Investment ResearchFitch Researchhttp://www.alacrastore.com/storecontent/ccbn/T2380792T2380792ccbn/T2380792norm11 Sep 2009 06:06:00 EST2380792Final Transcript of COV corporate analyst meeting, 10-Sep-09 12:00pm ETCovidien Plc.54.0000FinalCovidien Plc. Investor Meeting TranscriptCOV12:00pm ETTranscript...Cole Lannum Covidien Plc. - VP - IR Rich Meelia Covidien Plc. - Chairman, President, CEO Tim Wright Covidien Plc. - President - Pharmaceutical Products and Imaging Solutions Dr. Michael Giuliani Covidien Plc. - VP - R&D Joe Almeida Covidien Plc. - President, Medical Devices Dr. Michael Tarnoff Covidien Plc - Chief Medical Officer, Surgical Devices Dr. Homero Rivas UT Southwestern Medical Center - Assistant Professor, Division of GI/Endocrine Surgery Dr. Sayeed Ikramuddin University of Minnesota in Minneapolis - Associate Professor of Surgery and Director of Bariatric Surgery Scott Flora Covidien Plc. - President, Surgical Devices Paul Hermes Covidien Plc. - Vice President, Research and Development Dr. Ned Cosgriff Covidien Plc. - VP Medical/Clinical Affairs Dr. Howard Kaufman Huntington Cancer Center - Medical Director Dr. Peter Marcello Lahey Clinic - Vice Chair, Department of Colorectal Chuck Dockendorff Covidien Plc. - CFO Joe Woody Covidien Plc - Head of Vascular Amy McBride-Wendell... Credit & Investment ResearchThomson StreetEventsIRELAND - Caire Inc, a unit of the BioMedical Segment of Chart Industries Inc agreed to acquire the oxygen therapy business of Covidien PLC, a Dublin-based manufacturer and wholesaler of medical supplies and equipment. Terms were not disclosed.05 Sep 2009 07:46:46 EST13117W22307P16115Q22304JCaire IncCovidien-Oxygen Therapy BusinessChart Industries IncCovidien PLChttp://www.alacrastore.com/storecontent/Thomson_M%26A/Caire_Inc_acquires_Covidien_Oxygen_Therapy_Bus_from_Covidien_PLC-2105222040sdc/21052220402105222040Copyright © 2009, Thomson Financial, All Rights ReservedMeasuring, Medical, Photo Equipment; ClocksUnited StatesOrthopedic, prosthetic, and surgical supplies3842GAGeorgiaSubsidiary3842:Orthopedic, prosthetic, and surgical supplies3443:Fabricated plate work (boiler shops)3629:Electrical industrial apparatus, nec3823:Process control instrumentsMeasuring, Medical, Photo Equipment; ClocksIreland-RepSurgical and medical instruments and apparatus3841FFForeignSubsidiary1102740001Mnfr process control instrMnfr,whl healthcare prodUnspecifiedAssets1102745001Sep 5 20090.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.00000Caire Inc, headquartered inBall Ground, Georgia,manufactures respiratory careproducts such as liquid oxygenreservoirs and liquid oxygenportables. The company wasfounded in 1993.Caire Inc, headquartered in Ball Ground, Georgia,manufactures respiratory care products such as liquid oxygenreservoirs and liquid oxygen portables. The company wasfounded in 1993.Caire Inc, headquartered in Ball Ground, Georgia, manufactures respiratory care products such as liquid oxygen reservoirs and liquid oxygen portables. The company was founded in 1993.1.000002.00000Oxygen Therapy Business ofCovidienOxygen Therapy Business of CovidienOxygen Therapy Business of Covidien0.000000.000000.000000.00000Y03 Sep 09Thu, 03 Sep 2009 00:00:00 ESTDate Announced: 09/03/2009Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.000000.000000.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.00000IRELAND - Caire Inc, a unitof the BioMedical Segment ofChart Industries Inc agreedto acquire the oxygen therapybusiness of Covidien PLC, aDublin-based manufacturer andwholesaler of medicalsupplies and equipment. Termswere not disclosed.IRELAND - Caire Inc, a unit of the BioMedical Segment of Chart Industries Inc agreed to acquire the oxygen therapy business of Covidien PLC, a Dublin-based manufacturer and wholesaler of medical supplies and equipment. Terms were not disclosed.IRELAND - Caire Inc, a unit of the BioMedical Segment of Chart Industries Inc agreed toacquire the oxygen therapy business of Covidien PLC, a Dublin-based manufacturer andwholesaler of medical supplies and equipment. Terms were not disclosed.IRELAND - Caire Inc, a unit of the BioMedical Segment of Chart Industries Inc agreed to acquire the oxygen therapy business of Covidien PLC, a Dublin-based manufacturer and wholesaler of medicalsupplies and equipment. Terms were not disclosed.IRELAND - Caire Inc, a unit of the BioMedical Segment of Chart Industries Inc agreed to acquire the oxygen therapy business of CovidienPLC, a Dublin-based manufacturer and wholesaler of medical supplies and equipment. Terms were not disclosed.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002834:Pharmaceutical preparations3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies3845:Electromedical and electrotherapeutic apparatus5047:Medical, dental, and hospital equipment & supplies5122:Drugs, drug proprietaries, and druggists' sundries212814007NasdaqUnited States3443OhioPublicGTLS2834:Pharmaceutical preparations3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies3845:Electromedical and electrotherapeutic apparatus5047:Medical, dental, and hospital equipment & supplies5122:Drugs, drug proprietaries, and druggists' sundries676741003New YorkIreland-Rep3841ForeignPublicCOV0.000000.000000.000000.00000Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/ccbn/T2353366T2353366ccbn/T2353366norm05 Aug 2009 06:07:00 EST2353366Final Transcript of COV presentation, 5-Aug-09 2:15pm ETCovidien Plc.54.0000FinalCovidien Plc. at BMO Capital Markets Focus on Healthcare Conference TranscriptCOV2:15pm ETTranscript...Joanne Wuensch - BMO Capital Markets - Analyst Okay, everybody. Well, we're going to move on to the next one to try and stay on schedule. The next presentation is by the management of Covidien. We are very pleased to have here today Joe Almeida, President of the Medical Device segment at Covidien. Joe Almeida - Covidien - President Medical Devices Thank you, Joanne. Good afternoon. Just briefly go through the forward looking statements and the Safe Harbor. We're going to be making statements that you should be aware of. Our medical devices business within Covidien has experienced a solid growth. Year-to-date #### about #% operationally. We also have experienced very good launches of products in the last ## months. We just brought to market a brand new line of ... port called SILS Port as well as our Duet which is a buttress material built right onto a stapler. We're very focused... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2290206B2290206ccbn/B2290206norm30 Jul 2009 05:09:00 EST2290206Edited Brief of COV earnings conference call or presentation, 30-Jul-09 8:30am ETCovidien Plc.54.0000EditedCovidien Ltd. Q3 2009 Earnings Conference Call SummaryCOV8:30am ETBrief...Cole Lannum Covidien Plc. - VP IR Rich Meelia Covidien Plc. - Chairman, President and CEO Chuck Dockendorff Covidien Plc. - EVP and CFO CONFERENCE CALL PARTICIPANTS... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2290206T2290206ccbn/T2290206norm30 Jul 2009 10:07:00 EST2290206Final Transcript of COV earnings conference call or presentation, 30-Jul-09 8:30am ETCovidien Plc.54.0000FinalCovidien Ltd. Q3 2009 Earnings Conference Call TranscriptCOV8:30am ETTranscript...Cole Lannum Covidien Plc. - VP IR Rich Meelia Covidien Plc. - Chairman, President and CEO Chuck Dockendorff Covidien Plc. - EVP and CFO C O N F E R E N C E C A L L P A R T I C I P A N T S... Credit & Investment ResearchThomson StreetEventsUS - Covidien PLC acquired the US rights to experimental Opioid Pain Drug called Exalgo from Neuromed Pharmaceutical Inc, a Dublin, Ireland-based manufacturer and wholesaler of healthcare products. Terms were not disclosed.19 Jun 2009 07:57:17 EST22304J64244E22304J64210NCovidien PLCNeuromed Pharmaceutical Inc-US Rights to Experimental Opioid Pain DrugCovidien PLCNeuromed Pharmaceutical Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/Covidien_PLC_acquires_Neuromed_Pharm_US_Rights_to_Ex_from_Neuromed_Pharmaceutical_Inc-2083417020sdc/20834170202083417020Copyright © 2009, Thomson Financial, All Rights ReservedNew YorkMeasuring, Medical, Photo Equipment; ClocksIreland-RepSurgical and medical instruments and apparatus3841FFForeignPublicCOV2834:Pharmaceutical preparations3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies3845:Electromedical and electrotherapeutic apparatus5047:Medical, dental, and hospital equipment & supplies5122:Drugs, drug proprietaries, and druggists' sundries2834:Pharmaceutical preparations3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies3845:Electromedical and electrotherapeutic apparatus5047:Medical, dental, and hospital equipment & supplies5122:Drugs, drug proprietaries, and druggists' sundriesDrugsUnited StatesPharmaceutical preparations2834PAPennsylvaniaSubsidiary676741003Mnfr,whl healthcare prodMnfr pharmUnspecifiedAssets1088791001Jun 19 20090.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.00000Covidien Ltd, located inHamilton, Bermuda,manufactures and wholesaleshealthcare products. Itoperates through foursegments: Medical Devices,Imaging Solutions,Pharmaceutical Products, andMedical Supplies. Its brandsinclude Autosuture, Devon,Kendall, Mallinckrodt,Nellcor, Puritan Bennett,Syneture, and Valleylab. Thecompany was founded in 1994.Covidien Ltd, located in Hamilton, Bermuda, manufactures andwholesales healthcare products. It operates through foursegments: Medical Devices, Imaging Solutions, PharmaceuticalProducts, and Medical Supplies. Its brands includeAutosuture, Devon, Kendall, Mallinckrodt, Nellcor, PuritanBennett, Syneture, and Valleylab. The company was founded in1994.Covidien Ltd, located in Hamilton, Bermuda, manufactures and wholesales healthcare products. It operates through four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products, and Medical Supplies. Its brands include Autosuture, Devon, Kendall, Mallinckrodt, Nellcor, Puritan Bennett, Syneture, and Valleylab. The company was founded in 1994.1.000002.000003.000004.000005.000006.00000US Rights to ExperimentalOpioid Pain Drug called Exalgoof Neuromed PharmaceuticalInc, a manufacturer ofpharmaceuticals to treatchronic and neuropathic painUS Rights to Experimental Opioid Pain Drug called Exalgo ofNeuromed Pharmaceutical Inc, a manufacturer ofpharmaceuticals to treat chronic and neuropathic painUS Rights to Experimental Opioid Pain Drug called Exalgo of Neuromed Pharmaceutical Inc, a manufacturer of pharmaceuticals to treat chronic and neuropathic pain0.000000.000000.000000.00000Y17 Jun 09Wed, 17 Jun 2009 00:00:00 ESTDate Announced: 06/17/2009Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.000000.000000.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.00000US - Covidien PLC acquiredthe US rights to experimentalOpioid Pain Drug calledExalgo from NeuromedPharmaceutical Inc, a Dublin,Ireland-based manufacturerand wholesaler of healthcareproducts. Terms were notdisclosed.US - Covidien PLC acquired the US rights to experimental Opioid Pain Drug called Exalgo from Neuromed Pharmaceutical Inc, a Dublin, Ireland-based manufacturer and wholesaler of healthcare products. Terms were not disclosed.US - Covidien PLC acquired the US rights to experimental Opioid Pain Drug called Exalgofrom Neuromed Pharmaceutical Inc, a Dublin, Ireland-based manufacturer and wholesaler ofhealthcare products. Terms were not disclosed.US - Covidien PLC acquired the US rights to experimental Opioid Pain Drug called Exalgo from Neuromed Pharmaceutical Inc, a Dublin, Ireland-based manufacturer and wholesaler of healthcare products.Terms were not disclosed.US - Covidien PLC acquired the US rights to experimental Opioid Pain Drug called Exalgo from Neuromed Pharmaceutical Inc, a Dublin,Ireland-based manufacturer and wholesaler of healthcare products. Terms were not disclosed.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances676741003New YorkIreland-Rep3841ForeignPublicCOV2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances68433001Canada2834ForeignPrivate0.000000.000000.000000.00000Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/ccbn/T2273137T2273137ccbn/T2273137norm18 Jun 2009 03:04:00 EST2273137Final Transcript of COV presentation, 18-Jun-09 10:45am ETCovidien Ltd.54.0000FinalCovidien Ltd. at Jefferies & Co. Healthcare Conference TranscriptCOV10:45am ETTranscript...Chuck Dockerdorff Covidien Ltd. - EVP and CFO Tim Wright Covidien Ltd. - President, Pharmaceutical and Imaging P R E S E N T A T I O N... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/spcred/723235723235spcred/723235normglobal21 May 2009 10:34:31 EST175SummaryThe latest Summary from S&PUnited StatesHealth Care EquipmentUnited StatesGlobal IssuersSummaryUSA35101010 351010 3510 35Covidien Ltd.412374USACOVSUMMARYCapitalCORPGLOBISSCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/723234723234spcred/723234normglobal21 May 2009 10:34:00 EST400Full ReportThe latest Full Report from S&PUnited StatesUnited StatesFull ReportUSA35101010 351010 3510 35Covidien Ltd.412374USACOVFULLCapitalCORPGLOBISSGlobal IssuersHealth Care EquipmentCredit & Investment ResearchS&P Credit Research